Article
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.
Cellular oncology (Dordrecht, Netherlands) - 1 Jul 2013
Peled Nir, Wynes Murry W, Ikeda Norihiko, Ohira Tatsuo, Yoshida Koichi, Qian Jin, Ilouze Maya, Brenner Ronen, Kato Yasufumi, Mascaux Celine, Hirsch Fred R
Abstract excerpt
BACKGROUND: The insulin-like growth factor-1 receptor (IGF-1R) pathway is known to play a role in the acquisition of resistance to epidermal growth factor receptor (EGFR)-specific tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). However, its exact role in TKI resistance ha...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
